Vulnerability · Published Jun 18, 2026 · Assigned by icscert
CVE-2026-50034Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT Cleartext Transmission of Sensitive Information
Medium 6.5
In plain English
A medium-severity security flaw in Blood Glucose Monitoring System (Model No. APG-01 BT) from Apollo Pharmacy. There are no confirmed reports of exploitation so far. The chance it is exploited in the next 30 days is estimated at 0.2% (higher than 11% of all known vulnerabilities).
Severity (CVSS 3.1)6.5Medium
Exploit odds (30 days)0.2%top 88.9% of all CVEs
Exploited in the wildNo reportsCISA SSVC: none
Attack toolingNoneno public tooling known
Official description
An attacker within BLE communication range can passively intercept wireless traffic and obtain sensitive health-related information, including glucose measurement values.
Affected products (as reported)
| Vendor | Product | Versions |
|---|---|---|
| Apollo Pharmacy | Blood Glucose Monitoring System (Model No. APG-01 BT) | 0x0110_v1.1.0 |
Weakness: CWE-319 · Vector: CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N